Metaanalisis Revascularizacion vs Tto Medico
ESC Congress 2008 Clinical Trial Summary Slides. 3T/2R Troponin I or T >3x ULN at 48 hours: 20% for tirofiban vs. 35% for placebo (p = 0.009) MACE at.
Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program.
Jacob A. Udell, MD, MPH, Marc P. Bonaca, MD, MPH, Jean-Philippe Collet, MD, PhD, A. Michael Lincoff, MD, Dean J. Kereiakes, MD, Francesco Costa, MD, Cheol.
Eurheartj.ehv320.Full
2015 ESC Guidelines for the Management of NSTE-ACS
Acs Guideline 2015
